1.Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone
Haiwei JIANG ; Danfeng HE ; Huiquan XIAO
Journal of Traditional Chinese Medicine 1992;0(11):-
Objective To observe the effect of herbal treatment to strengthen spleen,tonify kidney,invigorate blood flow and dissolve phlegm plus Rosiglitazone on nonalcoholic fatty liver disease (NAFLD) with insulin resistance (IR).Methods The 90 cases were randomized into 3 groups:blank group of 29 cases;western medicine group of 32 cases,treated with Rosiglitazone;treatment group of 29 cases treated with herbal medicine plus Rosiglitazone.The changes in liver function,blood lipid,fasting blood glucose (FBG),fasting insulin (FIN),insulin resistance index (IRI),serum leptin and adiponcetin were observed.Results In the treatment group,changes of liver function,blood lipid,FBG,FIN,IRI,serum leptin and adiponcetin compared after treatment was significant (P
2.In-Vitro Anti-HBV Activity of Bushen Jianpi Formula
Wanwan HE ; Ni LIU ; Huiquan XIAO ; Riyong LUO ; Yutong ZHU
Journal of Guangzhou University of Traditional Chinese Medicine 2001;0(01):-
[Objective]: To study the in-vitro anti-HBV activity of Bushen Jianpi Formula (BJF). [Methods] 2.2.15 cell strain was cultured in vitro to observe the effect of BJF on its secretion of HBsAg and HBeAg. [Results] After the addition of BJF for ten days, median toxic concentration of BJF was 37.80g/L, median inhibitory concentrations of HBsAg and HBeAg were 19.05g/L and 9.55g/L, and the therapeutic index was 1.98and 3.96. [Conclusion] It is suggested that BJF has an in-vitro inhibitory effect on the secretion of HBeAg.
3.Plasma Levels of Some Neuropeptides in Patients with Primary Hypertension
Xing THENG ; Tonghua ZHANG ; Hongjun DING ; Chenghai WANG ; Hong XIAO ; Huiquan SHEN ; Debiao QIA
Academic Journal of Second Military Medical University 1981;0(04):-
Plasma concentrations of ?-endorphin (?-EP), leucine enkephalin (L-EK), neurotensin (NT), arginine vasopressin (AVP), renin activity (PRA) and angiotensin Ⅱ (AT Ⅱ ) were measured by radioimmunoassay in 60 normal persons and 120 hypertensive patients. There were lower levels of ?-EP and L-EK (P